Press Releases

Mestag Therapeutics appoints Prof. Ton Logtenberg as Chair

Mestag Therapeutics founding investigator Prof. David A. Tuveson elected to US National Academy of Medicine

Fierce Biotech names Mestag Therapeutics as one of its “Fierce 15” Biotech Companies of 2021

Mestag Therapeutics Extends Seed Financing to $45 Million and Welcomes New Investors Forbion, GV (formerly Google Ventures) and Northpond Ventures

Mestag Therapeutics announces collaboration with Janssen, focused on the discovery of novel fibroblast targets for the treatment of inflammatory disease

Mestag Therapeutics launches with seed financing of $11 million to develop therapeutics targeting activated fibroblast populations across inflammatory disease and cancer

Mestag Therapeutics congratulates Founder Professor David A. Tuveson upon his appointment as 2021 President of The American Association for Cancer Research